Sanjay Mohan

Academic / Other · 2 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acu Recurrent Acute Myeloid Leukemia	Phase 2	2023-04-13
Completed	Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies Diffuse Large B-cell Lymphoma, Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma	Phase 1	2019-06-21